ListedMainboardBook builtNSEBSE

Paras Healthcare IPO

₹660.00 to ₹693.00Price band

Listed on 28 October 2026 at an issue price of ₹693.00.

Subscription and grey market figures refresh on a 30-minute cycle. Last synced 15 November 2026. Confirm current numbers on the exchange websites before you apply.

Issue size
₹1,450.00 Cr
Lot size
21 shares
Minimum investment
₹14,553.00
Face value
₹1.00
Fresh issue
₹500.00 Cr
Offer for sale
₹950.00 Cr
Exchanges
NSE and BSE
Bidding dates
21 October 2026 to 23 October 2026

Listed on the exchange

Paras Healthcare priced its issue at ₹693.00 and began trading on 28 October 2026.

The dates that matter

An Indian IPO runs on a fixed calendar. Bidding stays open for three working days, the allotment is finalised the next working day, and the shares begin trading the day after that.

    Issue dates

  1. Anchor investor biddingCompleted

    19 October 2026

    One day before the public window, for institutional anchors.

  2. Bidding opensCompleted

    21 October 2026

  3. Bidding closesCompleted

    23 October 2026

  4. Basis of allotmentCompleted

    26 October 2026

  5. Refunds initiatedCompleted

    27 October 2026

  6. Shares credited to DematCompleted

    27 October 2026

  7. Listing on the exchangeCompleted

    28 October 2026

Grey market premium

Grey market premium is the price traders quote among themselves for shares that have not listed yet. Below is the full day-by-day record we hold for this issue, not only the latest figure, because the movement across the bidding window says more than any single day does.

-126537910614 Oct28 Oct
Grey market premium per share over 15 recorded days. Hover or use the arrow keys to read any day.
Grey market premium history for Paras Healthcare
DatePremium per share
2026-10-1483
2026-10-1595
2026-10-1695
2026-10-1796
2026-10-1892
2026-10-1978
2026-10-2050
2026-10-2125
2026-10-2213
2026-10-2311
2026-10-2412
2026-10-259
2026-10-2611
2026-10-2713
2026-10-2813
Day by day, 15 records
DatePremium per shareImplied listing priceImplied gain
28 October 2026₹13.00₹706.001.88%
27 October 2026₹13.00₹706.001.88%
26 October 2026₹11.00₹704.001.59%
25 October 2026₹9.00₹702.001.30%
24 October 2026₹12.00₹705.001.73%
23 October 2026₹11.00₹704.001.59%
22 October 2026₹13.00₹706.001.88%
21 October 2026₹25.00₹718.003.61%
20 October 2026₹50.00₹743.007.22%
19 October 2026₹78.00₹771.0011.26%
18 October 2026₹92.00₹785.0013.28%
17 October 2026₹96.00₹789.0013.85%
16 October 2026₹95.00₹788.0013.71%
15 October 2026₹95.00₹788.0013.71%
14 October 2026₹83.00₹83.000.00%

About Paras Healthcare

Paras Healthcare Ltd. runs eight hospitals under the Paras Health brand in Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar. The network held 2,211 beds as of June 30, 2026. It treats patients in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Those six specialty groups brought in 75.30% of revenue in Fiscal 2026. The company earns money from inpatient and outpatient care at its hospitals. It employed 4,670 people as of March 31, 2026, including 1,084 doctors and 1,937 nurses. Total income was INR 1,628.78 crore in Fiscal 2026.

Promoter

  • Dharminder Kumar Nagar

Financial highlights

The last three fiscal years as the offer document states them. Reading across a row shows whether the figure has grown, which is why the years run left to right.

Metric (₹ crore)Mar 2024Mar 2025Mar 2026Jun 2026
Assets1,477.661,810.452,071.142,202.88
Total Income1,151.021,314.211,628.78478.75
Profit After Tax-15.33-57.9843.8349.68
EBITDA154.41156.46335.58113.48
NET Worth338.51280.49394.94444.96
Reserves and Surplus328.75270.73384.84434.86
Total Borrowing923.921,232.121,393.861,429.49

Figures are in ₹ crore and reproduced from the offer document, covering Mar 2024 to Jun 2026. A dash means the document does not state that figure for that period. A fiscal year ending March is labelled by its closing month, and where the document states a figure on a different basis the label here follows the document rather than normalising it.

Key ratios

Valuation and return ratios calculated from the issuer's financials. These are the figures the issue price is usually judged against, and the offer document carries the working behind each one.

RatioValueWhat it measures
Earnings per share₹4.34Profit after tax divided by the number of shares.
P/E at the cap price159.68xIssue price divided by earnings per share. Lower is cheaper, but only against the same industry.
P/E after the issue37.72xThe same ratio recalculated on the larger post-issue share count.
Price to book17.72xIssue price against net assets per share.
Net asset value per share₹39.11What the company owns, less what it owes, per share.
Return on equity12.98%Profit earned on shareholders’ money.
Return on capital employed10.76%Profit earned on all the capital in the business, including debt.
Return on net worth12.98%The offer document’s own name for return on shareholders’ funds.
Debt to equity3.53xBorrowings against shareholders’ funds. Higher means more leverage.
Profit margin2.69%Profit after tax as a share of income.
Operating margin20.60%Operating profit as a share of income, before interest, tax and depreciation.
Market capitalisation₹7,498.34 CrValue of the company at the issue price.

Ratios are stated as published. A ratio that is absent here was not stated in the document, and is not the same as a ratio of zero.

What the money is for

Every issue states its objects in the offer document. These are reproduced from it, largest first, so you can see where most of the raise is going.

  • Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by Company

    ₹320.90 Cr

  • General Corporate Purposes

    ₹101.11 Cr

  • Issue Expenses

    ₹66.37 Cr

  • Investment in our wholly owned Subsidiary, PMHPL (which also operates hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL

    ₹54.10 Cr

Peer comparison

The offer document compares the issuer against listed companies in the same business, on earnings, book value and return on net worth. Paras Healthcare is the first row.

Peer comparison from the offer document. Paras Healthcare is the first row.
CompanyEPS (₹)P/ENAV per share (₹)RoNW
Paras Healthcare Ltd.This issue4.34—₹39.1112.98%
Apollo Hospitals Enterprise Ltd.135.0459.36₹657.5821.95%
Aster DM Quality Care Ltd.7.5391.89₹88.329.70%
Fortis Healthcare Ltd.13.855.43₹131.0711.08%
Global Health Ltd.20.7164.46₹147.0615.15%
Jupiter Lifeline Hospitals Ltd.5.9242.92₹47.1013.41%
Krishna Institute of Medical Sciences Ltd.6.03116.41₹56.1711.01%
Manipal Health Enterprises Ltd.7.7187₹63.2612.37%
Max Healthcare Institute Ltd.14.8362.1₹109.5314.33%
Narayana Hrudayalaya Ltd.39.6743.41₹222.0219.74%
Yatharth Hospital and Trauma Care Services Ltd.18.255.16₹184.7910.36%

Reproduced from the peer comparison in the offer document. A dash means the document does not state that figure for that company. It is absent, not zero. Ratios are reported on the basis named in the document, which is not always the same period for every company.

Who gets what share

SEBI fixes how much of a book-built issue each investor category can be allotted. This is the split for this issue as stated in the offer document.

Reservation by investor category
CategoryShare of issueAmount
Qualified institutional buyers30.00%₹435.00 Cr
Non-institutional (bids above ₹10 lakh)10.00%₹145.00 Cr
Retail individual investors10.00%₹145.00 Cr
Non-institutional (bids up to ₹10 lakh)5.00%₹72.50 Cr

Percentages are reproduced as text from the offer document. A dash means the document does not state an amount for that category. Categories are labelled using the document's own terms, which differ slightly between issues.

Questions people ask

One lot is 21 shares. The price band is ₹660.00 to ₹693.00, and the block is calculated at the top of it, ₹693.00. That comes to ₹14,553.00 held in your bank account until the allotment is finalised. If you are not allotted, the block is released and the money never leaves your account.

Bidding runs from 21 October 2026 to 23 October 2026. Applications can be revised or withdrawn while bidding is open. Once it closes, the registrar finalises the basis of allotment the next working day and shares are credited the day after.

The most recent recorded premium is ₹13.00 per share, against ₹83.00 when recording began on 14 October 2026. The movement across those days says more than either number on its own.

Retail applications run from 1 lot to 13 lots. The retail category caps an application at ₹2,00,000, so the upper limit is whichever comes first: the lot ceiling or the value ceiling.

We hold the issue price of ₹693.00 and the listing date of 28 October 2026, but our data source does not publish the listing-day open, close or gain, so we cannot state the listing price. The exchange page for this scrip carries the traded price.

Sources